Tuesday, February 20, 2018 12:41:26 PM
They clearly say the bulk of their R&D ....and if betabodies was not truly deep into R&D trials at all, they word it and play it off like all IP is moving to Oncologie but likely not.
As usual.....NO TRANSPARENCY
More questions than answers are left at the end and on top of it all, no open bidding system where someone else could pay more than a breadcrumbed upfront money
______
Notice what RIHC means when you read that...
"Paul Hastings " legal Andrew Taylor Kessel....
.... working for Gilead since July 2017 and Paul Hastings listed on the standstill agreement as the legal where one would refer jnquiries in regards to such Standstill Agreement, representing Peregrine Pharmaceuticals....oh, I mean CDMO now
__________
RIHC Those listed as Registered In-House Counsel (RIHC) are out-of-state attorneys. They have complied with rules permitting them to practice in California on a limited basis.
http://www.calbar.ca.gov/Portals/0/documents/members/Status.html
____
Logo
Attorney Search
Andrew Taylor Kessel - #802954
Current Status: RIHC
RIHC — explanation of "RIHC" status
See below for more details.
Profile Information
The following information is from the official records of The State Bar of California.
ID Number: 802954
Address: Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404
Map it Phone Number: (650) 522-5522
Fax Number: Not Available
Email: andrew.kessel@gilead.com
County: San Mateo
Undergraduate School: Northeastern Univ; Boston MA
District: N/A
Sections: None Law School: Boston Coll Law School; Newton MA
Status History
Effective Date Status Change
Present RIHC
7/7/2017 RIHC
7/7/2017 Registered with The State Bar of California
Explanation of licensee status
Actions Affecting Eligibility to Practice Law in California
Disciplinary and Related Actions
This attorney has no public record of discipline
http://members.calbar.ca.gov/fal/Member/Detail/802954
Recent CDMO News
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/19/2023 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:34:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:33:03 AM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM